0001209191-17-041458.txt : 20170622
0001209191-17-041458.hdr.sgml : 20170622
20170622183403
ACCESSION NUMBER: 0001209191-17-041458
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170620
FILED AS OF DATE: 20170622
DATE AS OF CHANGE: 20170622
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ra Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001481512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262908274
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 87 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
BUSINESS PHONE: (617) 401-4060
MAIL ADDRESS:
STREET 1: 87 CAMBRIDGE PARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mathers Edward T
CENTRAL INDEX KEY: 0001328625
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37926
FILM NUMBER: 17926031
MAIL ADDRESS:
STREET 1: C/O MEDIMMUNE, INC.
STREET 2: ONE MEDIMMUNE WAY
CITY: GAITHERSBURG
STATE: MD
ZIP: 20878
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2017-06-20
0
0001481512
Ra Pharmaceuticals, Inc.
RARX
0001328625
Mathers Edward T
2150 WOODWARD ST., STE. 100
AUSTIN
TX
78744
1
0
0
0
Options to Purchase Common Stock
22.37
2017-06-20
4
A
0
15000
0.00
A
2027-06-20
Common Stock
15000
15000
D
On June 20, 2017, the Reporting Person was granted an option to purchase 15,000 shares of Common Stock. The option shall vest and become exercisable in a single annual installment upon the earlier of (i) the anniversary of the grant date of June 20, 2017 or (ii) the Issuer's annual general meeting of shareholders in 2018.
/s/ Sasha Keough, Attorney-in-fact
2017-06-22